Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial reactive oxygen species (mROS) generation is a physiological process where superoxide, hydrogen peroxide, and hydroxyl radicals are produced, primarily as byproducts of electron leakage from the mitochondrial electron transport chain (Murphy, 2009, Biochem J). While low levels of mROS act as essential secondary messengers in redox signaling, excessive generation leads to oxidative damage to mitochondrial DNA, proteins, and membrane lipids (Zorov et al., 2014, Physiol Rev). This phenomenon is a hallmark of aging and plays a critical role in the progression of neurodegenerative diseases like Parkinson's and Alzheimer's, as well as cardiovascular disorders (Schieber & Chandel, 2014, Curr Biol). Therapeutic strategies often focus on neutralizing these species using mitochondria-targeted antioxidants like MitoQ or SkQ1, which accumulate in the mitochondrial matrix to scavenge radicals at their source (Smith & Murphy, 2010, Free Radic Biol Med). Other approaches include the use of small peptides like Elamipretide that stabilize the inner mitochondrial membrane to optimize electron flow and reduce leakage (Szeto, 2014, Br J Pharmacol). However, because mROS are also involved in essential cellular pathways like immune response and cell differentiation, indiscriminate suppression can lead to adverse effects or the antioxidant paradox (Gutteridge & Halliwell, 2010, Biochem Biophys Res Commun). Consequently, precise modulation of mROS generation remains a significant challenge in drug development.
Mitochondria-targeted scavenging of reactive species and stabilization of the electron transport chain to prevent electron leakage.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial reactive oxygen species generation (mROS generation) (mROS generation).